34 participants
A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2015-04-03
- Start Date:
- 2004-12-31
- Completion:
- 2006-01-31
Conditions
- Mucopolysaccharidosis I
- Hurler's Syndrome
- Hurler-Scheie Syndrome
- Scheie Syndrome
Interventions
- BIOLOGICAL